ukwelashwa kwe-metastatic non small cell lung cancer

I-Metastatic non-small cell lung cancer (mNSCLC) yisifo esiyinkimbinkimbi esidinga amasu okwelashwa komuntu siqu. Lo mhlahlandlela unikeza umbono wezindlela zokwelapha zakamuva, okuhlanganisa izindlela zokwelapha ezihlosiwe, ukwelashwa kwamasosha omzimba, ukwelashwa ngamakhemikhali, nokuhlolwa komtholampilo, ukunika iziguli amandla nemindeni yazo ulwazi lokwenza izinqumo ezinolwazi.Ukuqonda Umdlavuza We-Metastatic Non-Small Cell Lung CancerI-Metastatic non-small cell lung cancer, eyaziwa nangokuthi isiteji IV NSCLC, kusho ukuthi umdlavuza ususabalele usuka ephashini uye kwezinye izingxenye zomzimba. Izindawo ezivamile ze-metastasis zihlanganisa ubuchopho, amathambo, isibindi, nezindlala ze-adrenal. Nakuba umdlavuza we-metastatic ungaba inselele kakhulu ukuwelapha, ukuthuthuka kwezinketho zokwelapha kuye kwaba ngcono kakhulu imiphumela kanye nezinga lempilo leziguli eziningi. Ukuxilongwa kusenesikhathi kubalulekile, futhi ungafunda kabanzi mayelana nocwaningo lomdlavuza e-Shandong Baofa Cancer Research Institute.Izinhlobo Zomdlavuza Wamaphaphu Ongewona Amancane Izinhlobo ezimbili eziyinhloko ze-NSCLC i-adenocarcinoma kanye ne-squamous cell carcinoma. I-Adenocarcinoma iwuhlobo oluvame kakhulu futhi ivamise ukuvela kwabangabhemi. I-squamous cell carcinoma ivame ukuxhunyaniswa nokubhema. Ezinye izinhlobo ezingavamile kakhulu zihlanganisa i-cell carcinoma enkulu kanye ne-adenosquamous carcinoma. Ukuxilongwa okunembile kwe-subtype kubalulekile ekunqumeni indlela yokwelapha ephumelela kakhulu.I-Diagnosis and StagingDiagnosing ukwelashwa kwe-metastatic non small cell lung cancer ngokuvamile kuhilela inhlanganisela yokuhlolwa kwezithombe (CT scans, PET scans, MRI), biopsies, nokuhlolwa kwamangqamuzana. Ukuhlolwa kwamangqamuzana kuhlaziya amangqamuzana omdlavuza ukuze kutholwe ukuguqulwa kofuzo okuthile noma ama-biomarker angaqondiswa ngezindlela zokwelapha ezithile. Isiteji sinquma izinga lokusabalala komdlavuza, kusize odokotela balungise uhlelo lokwelapha.Izinketho Zokwelapha I-Metastatic Non-Small Cell Lung CancerUkwelashwa ukwelashwa kwe-metastatic non small cell lung cancer ngokuvamile i-systemic, okusho ukuthi ithinta wonke umzimba. Izindlela zokwelashwa ezijwayelekile zihlanganisa:Imithi yokwelapha ehlosiwe eqondiswe ngqo kuma-molecule athile (njengamaphrotheni noma ufuzo) asiza amangqamuzana omdlavuza ukuthi akhule futhi asakazeke. Lezi zindlela zokwelapha zivame ukusetshenziswa ezigulini ezinezimila ezinezinguquko ezithile zofuzo.I-EGFR InhibitorsI-Epidermal Growth Factor Receptor (EGFR) inhibitors isetshenziselwa iziguli ezinokuguqulwa kwe-EGFR. Ama-EGFR inhibitors avamile ahlanganisa: I-Osimertinib (Tagrisso) Erlotinib (Tarceva) Gefitinib (Iressa) Afatinib (Gilotrif)Le mithi ivimba amaprotheni e-EGFR, ivimbele amangqamuzana omdlavuza ukuthi angakhuli.ALK InhibitorsI-Anaplastic Lymphoma Kinase (ALK) inhibitors isetshenziselwa iziguli ezine-ALK rearrangements. Ama-ALK inhibitors avamile ahlanganisa: I-Alectinib (Alecensa) Brigatinib (Alunbrig) Ceritinib (Zykadia) Crizotinib (Xalkori)Le mithi ivimba iphrotheni ye-ALK, ibambezela noma imise ukukhula komdlavuza.Ezinye Izindlela Zokwelapha EzihlosiweOkunye okuhlosiwe kuhlanganisa i-ROS1, i-BRAF, i-MET, i-NTRK, ne-RET. I-oncologist yakho izonquma ukuthi umdlavuza wakho unazo yini lezi zinguquko.Imishanguzo ye-ImmunotherapyImmunotherapy isiza amasosha akho omzimba ukubona futhi ahlasele amangqamuzana omdlavuza. Lezi zindlela zokwelapha zivame ukusetshenziswa njengendlela yokwelapha yomugqa wokuqala ukwelashwa kwe-metastatic non small cell lung cancer.PD-1 kanye ne-PD-L1 InhibitorsLe mithi ivimba i-PD-1 (iphrotheni yokufa kweseli ehleliwe 1) noma i-PD-L1 (i-programmed cell death ligand 1) amaprotheni, esiza amangqamuzana omdlavuza ukuba agweme amasosha omzimba. I-PD-1 ne-PD-L1 inhibitors evamile ihlanganisa: I-Pembrolizumab (Keytruda) Nivolumab (Opdivo) Atezolizumab (Tecentriq) Durvalumab (Imfinzi) - Ivame ukusetshenziswa ngemva kwe-chemoradiation esigabeni III NSCLC.Le mithi ingasetshenziswa yodwa noma ihlanganiswe ne-chemotherapy.CTLAtorsThe-4 blockhitors(CTLA-4) I-T-lymphocyte-associated protein 4), esiza amangqamuzana omdlavuza ukuba agweme amasosha omzimba. I-Ipilimumab (Yervoy) iyi-CTLA-4 inhibitor evamile, ngezinye izikhathi isetshenziswa ngokuhambisana ne-PD-1 inhibitors.Izidakamizwa ze-ChemotherapyChemotherapy zisebenzisa amakhemikhali anamandla ukubulala amangqamuzana omdlavuza. Nakuba izindlela zokwelapha ezihlosiwe kanye nama-immunotherapies sekwande kakhulu, ukwelashwa ngamakhemikhali kuseyindlela yokwelapha evamile, ikakhulukazi uma ihlangene nezinye izindlela zokwelapha. Imithi ejwayelekile ye-chemotherapy esetshenziselwa ukwelashwa kwe-metastatic non small cell lung cancer hlanganisa: Izidakamizwa ezisekelwe ku-Platinum (Cisplatin, Carboplatin) Taxanes (Paclitaxel, Docetaxel) Pemetrexed (Alimta) Gemcitabine (Gemzar)Ukwelapha ngemisebeUkwelashwa kweRadiation kusebenzisa imisebe yamandla aphezulu ukubulala amangqamuzana omdlavuza. Ivamise ukusetshenziselwa ukudambisa izimpawu ezinjengobuhlungu noma ukuphelelwa umoya lapho umdlavuza ususabalele ezindaweni ezithile njengethambo noma ubuchopho. Ingase futhi isetshenziselwe ukwelapha isimila samaphaphu esiyinhloko.UkuhlinzwaUkuhlinzwa ngokuvamile akukona ukwelashwa okuyinhloko ukwelashwa kwe-metastatic non small cell lung cancer, kodwa ingasetshenziswa ezimweni ezithile ukuze kususwe i-metastasis eyodwa, ikakhulukazi ebuchosheni noma ezindlala ze-adrenal. Lokhu kuvame ukuba yingxenye yohlelo lokwelapha olubanzi.Isivivinyo SemitholampiloIzivivinyo zezokwelapha izifundo zocwaningo ezihlola ukwelapha okusha komdlavuza. Banikeza iziguli ithuba lokuthola izindlela zokwelapha ezisezingeni eliphezulu ezingakatholakali kabanzi. Cabangela ukuxoxa ngezinketho zesilingo somtholampilo nodokotela wakho. I-Shandong Baofa Cancer Research Institute ibamba iqhaza ngenkuthalo futhi ikhuthaze ucwaningo lwezokwelashwa.Ukulawula Imiphumela Emibi Ukwelashwa komdlavuza kungabangela imiphumela engemihle. Udokotela wakho angakusiza ukuphatha le miphumela engemihle ngemithi nokunye ukunakekelwa okusekelayo. Imiphumela emibi evamile ihlanganisa ukukhathala, isicanucanu, ubuhlungu, nokulahlekelwa izinwele. Kubalulekile ukuxhumana nanoma yimiphi imiphumela emibi oyitholayo nethimba lakho lezokunakekelwa kwezempilo.Izibikezelo kanye Namazinga OkusindaIsibikezelo ukwelashwa kwe-metastatic non small cell lung cancer kuyahlukahluka kuye ngezici eziningana, okuhlanganisa isigaba somdlavuza, impilo yesiguli iyonke, kanye nokwelashwa okuqondile okutholiwe. Nakuba lesi sifo ngokuvamile sithuthukile, amazinga okusinda aye athuthuka kakhulu ngokuthuthukiswa kwezindlela zokwelapha ezintsha. Xoxa ngesifo sakho somuntu ngamunye nodokotela wakho we-oncologist.I-Palliative CarePalliative Care igxile ekudambiseni izimpawu kanye nokwenza ngcono izinga lempilo yeziguli ezinezifo ezimbi kakhulu, okuhlanganisa nomdlavuza wamaphaphu we-metastatic. Ingahlinzekwa kunoma yisiphi isigaba sesifo, futhi ivame ukusetshenziswa ngokuhambisana nezinye izindlela zokwelapha. Ukunakekelwa kwe-Palliative kungasiza ekulawuleni ubuhlungu, ukuphelelwa umoya, ukukhathala, nezinye izimpawu.Izinto Ezibalulekile Ezicatshangwayo Ngezinqumo ZokwelashwaUkukhetha ukwelashwa okufanele ukwelashwa kwe-metastatic non small cell lung cancer kuyisinqumo esiyinkimbinkimbi okufanele sithathwe ngokubonisana nodokotela wakho we-oncologist. Nazi ezinye izinto ezibalulekile ezicatshangelwayo: Imiphumela yokuhlolwa kwamangqamuzana: Ukuqonda izinguquko ezithile zofuzo noma ama-biomarker kumangqamuzana omdlavuza wakho kubalulekile ekunqumeni ukuthi ingabe izindlela zokwelapha ezihlosiwe ziyinketho. Sekukonke Impilo: Impilo yakho yonke kanye neleveli yokufaneleka izoba nomthelela ekutheni iziphi izindlela zokwelapha ezifanele. Imigomo Yokwelapha: Xoxa ngemigomo yakho yokwelashwa nodokotela wakho, noma ngabe ukwalula ukuphila, ukuthuthukisa izinga lempilo, noma kokubili. Imiphumela Emibi: Qonda imiphumela emibi engaba khona yenketho ngayinye yokwelashwa nokuthi ingaphathwa kanjani. Izilingo Zomtholampilo: Cabanga ukuthi ukuhlanganyela ovivinyweni lomtholampilo kukulungele yini.Intuthuko Yakamuva Ekwelapheni Umdlavuza WamaphaphuUmkhakha wokwelashwa komdlavuza wamaphaphu uthuthuka ngokushesha. Izindlela zokwelapha ezintsha nezindlela zokwenza zithuthukiswa njalo. Ezinye zentuthuko yakamuva zihlanganisa: Ama-antibody-drug conjugates (ADCs): Le mithi ihlanganisa ukucaciswa kokwelashwa okuqondiwe namandla okubulala amaseli e-chemotherapy. Ama-antibodies ama-Bispecific: Lawa masosha omzimba abandakanya amaseli omzimba ukuze aqondise futhi abulale amangqamuzana omdlavuza. Amasu athuthukisiwe emisebe: Amasu afana ne-stereotactic body radiation therapy (SBRT) aletha imithamo ephezulu yemisebe ezimila kuyilapho enciphisa ukulimala kwezicubu ezizungezile. ukwelashwa kwe-metastatic non small cell lung cancer kungaba inselele, kodwa kunezinsiza eziningi ezitholakalayo zokusiza iziguli kanye nemindeni yazo. Amaqembu okusekela, ukwelulekwa, kanye nemiphakathi eku-inthanethi inganikeza ukusekelwa ngokomzwelo nezeluleko ezisebenzayo. Ukugcina indlela yokuphila enempilo, kuhlanganise nokudla okulinganiselayo nokuzivocavoca njalo, kungathuthukisa izinga lempilo. Umshwana wokuzihlangula: Lolu lwazi luhloselwe ulwazi olujwayelekile kanye nezinjongo zolwazi kuphela, futhi aluhlanganisi iseluleko sezokwelapha. Kubalulekile ukubonisana nochwepheshe bezempilo abaqeqeshiwe nganoma yikuphi ukukhathazeka ngezempilo noma ngaphambi kokwenza noma yiziphi izinqumo ezihlobene nempilo noma ukwelashwa kwakho.Izinsiza Zangaphandle:I-American Cancer Society - Ukwelapha Umdlavuza Wamaphaphu Ongewona Owomncane NgesitejiI-Cancer.Net - Umdlavuza Wamaphaphu - Ingqamuzana Elingewona Amancane - Izinketho ZokwelashwaNational Comprehensive Cancer Network (NCCN) - Non-Small Cell Lung Cancer Guidelines for Patients (PDF)Izithenjwa: Idatha nolwazi olwethulwa kusekelwe olwazini lwamanje lwezokwelapha futhi kutholwe ezinhlanganweni zezokwelapha ezinedumela elihle kusukela ngo-Okthoba 26, 2023.